Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 276

Related Citations for PubMed (Select 9152290)

1.

Efficacy and safety of one year of growth hormone therapy in steroid-dependent nephrotic syndrome.

Loke KY, Yap HK, Zhou X, Tan SP, Chao SM, Lee KO.

J Pediatr. 1997 May;130(5):793-9.

PMID:
9152290
3.
4.

Follow-up of linear growth of body height in children with nephrotic syndrome.

Hung YT, Yang LY.

J Microbiol Immunol Infect. 2006 Oct;39(5):422-5.

PMID:
17066206
5.

Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.

Simmonds J, Grundy N, Trompeter R, Tullus K.

Arch Dis Child. 2010 Feb;95(2):146-9. doi: 10.1136/adc.2007.129957.

PMID:
20172895
6.

Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.

Azcona C, Preece MA, Rose SJ, Fraser N, Rappaport R, Ranke MB, Savage MO.

Clin Endocrinol (Oxf). 1999 Dec;51(6):787-92.

PMID:
10619985
7.

Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.

Ogilvy-Stuart AL, Stirling HF, Kelnar CJ, Savage MO, Dunger DB, Buckler JM, Shalet SM.

Clin Endocrinol (Oxf). 1997 May;46(5):571-8.

PMID:
9231053
8.

Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy.

Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AJ, Baptista J, Kuntze J, Blizzard RM, Cara JF, Chernausek SD, et al.

J Pediatr. 1993 Aug;123(2):215-22.

PMID:
8345416
9.
10.

Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.

Sääf M, Hilding A, Thorën M, Troell S, Hall K.

Eur J Endocrinol. 1999 May;140(5):390-9.

11.
12.
13.

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.

Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2000 Oct;53(4):453-9.

PMID:
11012570
14.

European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimens.

Phillip M, Lebenthal Y, Lebl J, Zuckerman-Levin N, Korpal-Szczyrska M, Marques JS, Steensberg A, Jons K, Kappelgaard AM, Ibanez L; European Norditropin SGA Study Group.

Horm Res. 2009 Jan;71(1):52-9. doi: 10.1159/000173742. Epub 2008 Nov 27.

PMID:
19039237
15.
16.
17.

Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age.

Sas T, Mulder P, Aanstoot HJ, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.

Clin Endocrinol (Oxf). 2001 Feb;54(2):243-51.

PMID:
11207640
18.

Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age.

Rongen-Westerlaken C, van Es A, Wit JM, Otten BJ, De Muinck Keizer-Schrama SM, Drayer NM, Oostdijk W, Delemarre-vd Waal HA, Gons MH, Waelkens JJ, et al.

Am J Dis Child. 1992 Jul;146(7):817-20.

PMID:
1496949
19.

Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data.

Soliman AT, El Banna N, Abdel Fattah M, ElZalabani MM, Ansari BM.

Metabolism. 1998 May;47(5):541-8.

PMID:
9591744
20.

GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.

Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2003 Dec;59(6):779-87.

PMID:
14974922
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk